These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 2578522

  • 1. Activation of the alternative pathway of complement by human peripheral nerve myelin.
    Koski CL, Vanguri P, Shin ML.
    J Immunol; 1985 Mar; 134(3):1810-4. PubMed ID: 2578522
    [Abstract] [Full Text] [Related]

  • 2. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ, Ramsey J, Hammer CH, Frank MM.
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [Abstract] [Full Text] [Related]

  • 3. Effect of gangliosides on activation of the alternative pathway of human complement.
    Michalek MT, Bremer EG, Mold C.
    J Immunol; 1988 Mar 01; 140(5):1581-7. PubMed ID: 3346542
    [Abstract] [Full Text] [Related]

  • 4. Interactions of chrysotile asbestos fibres with the complement system.
    Saint-Remy JM, Cole P.
    Immunology; 1980 Oct 01; 41(2):431-7. PubMed ID: 6904360
    [Abstract] [Full Text] [Related]

  • 5. Activation of the alternative pathway of complement by Acanthamoeba culbertsoni.
    Ferrante A, Rowan-Kelly B.
    Clin Exp Immunol; 1983 Nov 01; 54(2):477-85. PubMed ID: 6418422
    [Abstract] [Full Text] [Related]

  • 6. The role of immunoglobulins in alternative complement pathway activation by zymosan. I. Human IgG with specificity for Zymosan enhances alternative pathway activation by zymosan.
    Schenkein HA, Ruddy S.
    J Immunol; 1981 Jan 01; 126(1):7-10. PubMed ID: 6778918
    [Abstract] [Full Text] [Related]

  • 7. Activation of the complement system and leukocyte recruitment by Tityus serrulatus scorpion venom.
    Bertazzi DT, de Assis-Pandochi AI, Talhaferro VL, Caleiro Seixas Azzolini AE, Pereira Crott LS, Arantes EC.
    Int Immunopharmacol; 2005 Jun 01; 5(6):1077-84. PubMed ID: 15829423
    [Abstract] [Full Text] [Related]

  • 8. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM.
    J Immunol; 1983 Nov 01; 131(5):2563-9. PubMed ID: 6355296
    [Abstract] [Full Text] [Related]

  • 9. Activation of the alternative pathway of human complement by haemoglobin.
    Wilson WA, Thomas EJ.
    Clin Exp Immunol; 1979 Apr 01; 36(1):140-4. PubMed ID: 111881
    [Abstract] [Full Text] [Related]

  • 10. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ.
    J Immunol; 1986 May 01; 136(9):3378-83. PubMed ID: 3485688
    [Abstract] [Full Text] [Related]

  • 11. CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytes.
    Marquart HV, Svehag SE, Leslie RG.
    J Immunol; 1994 Jul 01; 153(1):307-15. PubMed ID: 7515925
    [Abstract] [Full Text] [Related]

  • 12. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
    Inada K.
    Jpn J Exp Med; 1980 Feb 01; 50(1):13-21. PubMed ID: 6770130
    [Abstract] [Full Text] [Related]

  • 13. Consumption of C3 via the classical and alternative complement pathways by sera and synovial fluids from patients with rheumatoid arthritis.
    Hunder GG, McDuffie FC, Clark RJ.
    J Clin Lab Immunol; 1979 Nov 01; 2(4):269-73. PubMed ID: 119858
    [Abstract] [Full Text] [Related]

  • 14. Activation of the alternative pathway of complement by Entamoeba histolytica.
    Ortiz-Ortiz L, Capin R, Capin NR, Sepúlveda B, Zamacona G.
    Clin Exp Immunol; 1978 Oct 01; 34(1):10-8. PubMed ID: 219975
    [Abstract] [Full Text] [Related]

  • 15. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV, Shibanova ED, Zinchenko AA.
    Biokhimiia; 1987 Apr 01; 52(4):660-6. PubMed ID: 3647798
    [Abstract] [Full Text] [Related]

  • 16. Evasion of the alternative complement pathway by metacyclic trypomastigotes of Trypanosoma cruzi: dependence on the developmentally regulated synthesis of surface protein and N-linked carbohydrate.
    Sher A, Hieny S, Joiner K.
    J Immunol; 1986 Nov 01; 137(9):2961-7. PubMed ID: 3531342
    [Abstract] [Full Text] [Related]

  • 17. The influence of classical pathway components during alternative pathway--modulated immune complex aggregation: the role of C1 INH.
    Gronski P, Bodenbender L, Kanzy EJ, Seiler FR.
    Behring Inst Mitt; 1984 Nov 01; (76):29-41. PubMed ID: 6335396
    [Abstract] [Full Text] [Related]

  • 18. In vitro activation of complement by isolated human heart subcellular membranes.
    Giclas PC, Pinckard RN, Olson MS.
    J Immunol; 1979 Jan 01; 122(1):146-51. PubMed ID: 762412
    [Abstract] [Full Text] [Related]

  • 19. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E, Platt JL, Howell DN, Marsh HC, Frank MM.
    J Immunol; 1999 Sep 15; 163(6):3549-58. PubMed ID: 10477630
    [Abstract] [Full Text] [Related]

  • 20. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
    Densen P, McRill CM, Ross SC.
    J Immunol; 1988 Dec 01; 141(11):3902-9. PubMed ID: 3141507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.